Who owns Celldex Therapeutics Inc (CLDX)? Superinvestor holders

1 superinvestor of the 157 tracked here holds Celldex Therapeutics Inc (CLDX) in their latest 13F filing, a position of $44M. Julian and Felix Baker gives it the most weight: 0.22% of the reported portfolio. In their latest reported quarter, Julian and Felix Baker added.

Hold it now
1
of 157 tracked
Combined value
$44M
Bought / sold
1 / 0
last quarter

Key facts

Superinvestors holding it
1 of 157
Biggest holder
Julian and Felix Baker, $44M
Largest weight
Julian and Felix Baker, 0.22%of their portfolio
Combined value
$44M
Bought last quarter
1
Sold last quarter
0

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding CLDX, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Julian and Felix BakerBaker Bros. Advisors0.22%$44M1.18M▲ Added 78%+517.25KQ2 2026

Quarter by quarter

Superinvestor ownership of CLDX by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 2026920——00
Q2 202615711.18M$44M10
Q1 202615723.9M$123.6M10
Q4 20251571665.37K$18.1M00
Q3 202515724.56M$117.9M10
Q2 20251571665.37K$13.5M10
Q1 20251561247.64K$4.5M01
Q4 20241561247.64K$6.3M00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of CLDX held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Julian and Felix Baker·1.18M665.37K665.37K665.37K665.37K247.64K247.64K
Steve Cohen·—3.23M—3.89M———

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own CLDX?

In their latest 13F filings: Julian and Felix Baker (0.22% of the portfolio, $44M).

Who bought CLDX last quarter?

Julian and Felix Baker (added 78%). “Last quarter” is each investor's latest reported quarter.

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Celldex Therapeutics Inc (CLDX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/CLDX/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to CLDX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.